Aperio Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $126M | Sell |
547,545
-34,233
| -6% | -$7.89M | 0.37% | 46 |
|
|
2020
Q3 | $148M | Buy |
581,778
+3,867
| +0.7% | +$958K | 0.5% | 36 |
|
|
2020
Q2 | $136M | Buy |
577,911
+41,766
| +8% | +$9.53M | 0.5% | 32 |
|
|
2020
Q1 | $109M | Buy |
536,145
+16,905
| +3% | +$3.69M | 0.48% | 36 |
|
|
2019
Q4 | $125M | Buy |
519,240
+26,373
| +5% | +$5.81M | 0.45% | 36 |
|
|
2019
Q3 | $95.4M | Buy |
492,867
+61,925
| +14% | +$11.9M | 0.38% | 46 |
|
|
2019
Q2 | $79.4M | Sell |
430,942
-70,352
| -14% | -$12.6M | 0.32% | 53 |
|
|
2019
Q1 | $95.2M | Buy |
501,294
+15,702
| +3% | +$3M | 0.41% | 41 |
|
|
2018
Q4 | $94.5M | Buy |
485,592
+3,952
| +0.8% | +$771K | 0.48% | 34 |
|
|
2018
Q3 | $99.8M | Buy |
481,640
+12,311
| +3% | +$2.43M | 0.44% | 37 |
|
|
2018
Q2 | $86.6M | Buy |
469,329
+21,376
| +5% | +$3.78M | 0.41% | 40 |
|
|
2018
Q1 | $76.4M | Buy |
447,953
+5,756
| +1% | +$1.06M | 0.38% | 46 |
|
|
2017
Q4 | $76.9M | Buy |
442,197
+50,291
| +13% | +$8.9M | 0.39% | 44 |
|
|
2017
Q3 | $73.1M | Buy |
391,906
+26,900
| +7% | +$4.77M | 0.41% | 44 |
|
|
2017
Q2 | $62.9M | Buy |
365,006
+30,467
| +9% | +$4.96M | 0.38% | 44 |
|
|
2017
Q1 | $54.9M | Buy |
334,539
+25,405
| +8% | +$4.22M | 0.38% | 45 |
|
|
2016
Q4 | $45.2M | Sell |
309,134
-51,601
| -14% | -$7.77M | 0.35% | 52 |
|
|
2016
Q3 | $60.2M | Buy |
360,735
+18,266
| +5% | +$3.09M | 0.44% | 42 |
|
|
2016
Q2 | $52.1M | Buy |
342,469
+24,171
| +8% | +$3.76M | 0.41% | 46 |
|
|
2016
Q1 | $47.7M | Buy |
318,298
+7,110
| +2% | +$1.06M | 0.41% | 47 |
|
|
2015
Q4 | $50.5M | Buy |
311,188
+25,170
| +9% | +$3.96M | 0.46% | 39 |
|
|
2015
Q3 | $39.6M | Buy |
286,018
+19,504
| +7% | +$3.07M | 0.4% | 44 |
|
|
2015
Q2 | $40.9M | Buy |
266,514
+23,524
| +10% | +$3.77M | 0.42% | 41 |
|
|
2015
Q1 | $38.8M | Buy |
242,990
+13,678
| +6% | +$2.15M | 0.44% | 38 |
|
|
2014
Q4 | $36.5M | Buy |
229,312
+13,884
| +6% | +$2.16M | 0.45% | 35 |
|
|
2014
Q3 | $30.3M | Buy |
215,428
+15,262
| +8% | +$1.99M | 0.41% | 42 |
|
|
2014
Q2 | $23.7M | Sell |
200,166
-10,299
| -5% | -$1.19M | 0.34% | 55 |
|
|
2014
Q1 | $26M | Buy |
+210,465
| New | +$25.5M | 0.36% | 43 |
|
|
2013
Q4 | – | Sell |
-176,616
| Closed | -$20.1M | – | 47 |
|
|
2013
Q3 | $19.8M | Buy |
176,616
+26,336
| +18% | +$2.86M | 0.38% | 38 |
|
|
2013
Q2 | $14.8M | Buy |
+150,280
| New | +$15.6M | 0.35% | 44 |
|
Other funds holding AMGN
Aperio Group's AMGN Position: Q4 2020 in Review
Aperio Group reduced its Amgen (AMGN) stake by 5.9% in Q4 2020, selling an estimated $7.89M and leaving 547,545 shares worth $126M. The position accounts for 0.37% of the portfolio, ranked #46.
Aperio Group first reported a position in AMGN in Q2 2013 and has held it in 30 quarters since. The position peaked at $148M in Q3 2020. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.
- Aperio Group held 547,545 shares of Amgen worth $126M as of Q4 2020.
- Aperio Group sold 34,233 Amgen shares in Q4 2020, an estimated $7.89M.
- Amgen made up 0.37% of Aperio Group's portfolio in Q4 2020, its #46 holding.
- Aperio Group first reported a position in Amgen in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Amgen position peaked at $148M in Q3 2020.
- 2,219 funds tracked by Wall St. Rank held Amgen as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.